• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼓室内注射地塞米松治疗急性主观性耳鸣疗效的预后因素

Prognostic factors for the outcomes of intratympanic dexamethasone in the treatment of acute subjective tinnitus.

作者信息

An Yong-Hwi, Yu Kwang-Kyu, Kwak Min Young, Yoon Sang Won, Shim Hyun Joon

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.

出版信息

Otol Neurotol. 2014 Sep;35(8):1330-7. doi: 10.1097/MAO.0000000000000526.

DOI:10.1097/MAO.0000000000000526
PMID:25080038
Abstract

OBJECTIVE

To determine the prognostic factors for the outcomes of treating acute subjective tinnitus with intratympanic dexamethasone (ITD).

STUDY DESIGN

Retrospective chart review.

SETTING

Tertiary referral center.

PATIENTS

We enrolled 139 subjects who were treated with ITD for acute subjective tinnitus with symptoms lasting for 3 months or less. Overall, 114 of 139 subjects completed questionnaires 3 months after treatment or fully recovered within 3 months. Audiograms were performed 3 months after treatment in 43 patients.

INTERVENTION

ITD for acute subjective tinnitus.

MAIN OUTCOME MEASURE

Quantitative assessment of the severity of tinnitus by questionnaires and changes in hearing thresholds at all frequencies by pure-tone audiometry.

RESULTS

Tinnitus was cured in 43 of 114 patients (37.7%) within 3 months. The mean tinnitus loudness score, the mean tinnitus awareness score, and the mean tinnitus handicap inventory score were significantly reduced at 3 months after ITD. Audiometric responses were detected in 12 of 43 patients (27.9%) who underwent follow-up audiograms. The cure rate was significantly greater in patients with symptoms lasting for 2 weeks or less than in patients with symptoms lasting for more than 1 month (64.7% vs. 15.7%; p < 0.05). The mean global improvement index for tinnitus was significantly greater in patients with unilateral tinnitus than in patients with bilateral tinnitus (6.2 ± 1.9 vs. 5.0 ± 2.0; p < 0.05). Among patients with unilateral tinnitus, the audiometric response rate was significantly greater in patients with asymmetric hearing threshold than in patients with symmetric hearing threshold (48.8% vs. 4.8%; p < 0.01). The cure rate was significantly associated with the duration of symptoms. Unilateral tinnitus and audiologic asymmetry were positively associated with the audiometric response rate.

CONCLUSIONS

The duration of symptoms affected the cure rate of ITD for acute subjective tinnitus. Unilateral tinnitus was associated with better improvements in symptoms than bilateral tinnitus. Furthermore, unilateral tinnitus and audiologic asymmetry were positively associated with the audiometric response.

摘要

目的

确定鼓室内注射地塞米松(ITD)治疗急性主观性耳鸣疗效的预后因素。

研究设计

回顾性病历审查。

研究地点

三级转诊中心。

患者

我们纳入了139例因急性主观性耳鸣接受ITD治疗且症状持续3个月或更短时间的受试者。总体而言,139例受试者中有114例在治疗3个月后完成问卷调查或在3个月内完全康复。43例患者在治疗3个月后进行了听力图检查。

干预措施

ITD治疗急性主观性耳鸣。

主要观察指标

通过问卷调查对耳鸣严重程度进行定量评估,以及通过纯音听力测定法评估所有频率的听力阈值变化。

结果

114例患者中有43例(37.7%)在3个月内耳鸣治愈。ITD治疗3个月后,平均耳鸣响度评分、平均耳鸣知晓度评分和平均耳鸣残障量表评分均显著降低。43例接受随访听力图检查的患者中有12例(27.9%)检测到听力测定反应。症状持续2周或更短时间的患者治愈率显著高于症状持续超过1个月的患者(64.7%对15.7%;p<0.05)。单侧耳鸣患者的耳鸣总体改善指数显著高于双侧耳鸣患者(6.2±1.9对5.0±2.0;p<0.05)。在单侧耳鸣患者中,听力阈值不对称的患者听力测定反应率显著高于听力阈值对称的患者(48.8%对4.8%;p<0.01)。治愈率与症状持续时间显著相关。单侧耳鸣和听力不对称与听力测定反应率呈正相关。

结论

症状持续时间影响ITD治疗急性主观性耳鸣的治愈率。单侧耳鸣比双侧耳鸣症状改善更好。此外,单侧耳鸣和听力不对称与听力测定反应呈正相关。

相似文献

1
Prognostic factors for the outcomes of intratympanic dexamethasone in the treatment of acute subjective tinnitus.鼓室内注射地塞米松治疗急性主观性耳鸣疗效的预后因素
Otol Neurotol. 2014 Sep;35(8):1330-7. doi: 10.1097/MAO.0000000000000526.
2
Comparison of Long-Term Outcome of Intratympanic Dexamethasone Therapy between Acute Noise-Induced Tinnitus and Acute Idiopathic Tinnitus.急性噪声性耳鸣与急性特发性耳鸣鼓室内注射地塞米松治疗的长期疗效比较
J Int Adv Otol. 2017 Apr;13(1):53-60. doi: 10.5152/iao.2016.2632. Epub 2017 Jan 13.
3
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.全身治疗失败后鼓室内注射地塞米松治疗突发性感音神经性听力损失
Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15.
4
Comparison of various treatment modalities for acute tinnitus.各种急性耳鸣治疗方式的比较。
Laryngoscope. 2011 Dec;121(12):2619-25. doi: 10.1002/lary.22350.
5
[Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease].鼓室内注射庆大霉素和地塞米松治疗难治性梅尼埃病的疗效
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jan 20;31(2):96-99. doi: 10.13201/j.issn.1001-1781.2017.02.004.
6
Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial.鼓室内治疗难治性单侧梅尼埃病:庆大霉素或地塞米松?一项随机对照试验。
Otolaryngol Head Neck Surg. 2012 Mar;146(3):430-7. doi: 10.1177/0194599811429432. Epub 2011 Nov 18.
7
Clinical effect of intratympanic dexamethasone injection in acute unilateral tinnitus: A prospective, placebo-controlled, multicenter study.鼓室内注射地塞米松治疗急性单侧耳鸣的临床疗效:一项前瞻性、安慰剂对照、多中心研究。
Laryngoscope. 2018 Jan;128(1):184-188. doi: 10.1002/lary.26541. Epub 2017 Feb 22.
8
Predictive Factors for the Success of Intratympanic Dexamethasone Treatment of Acute Subjective Tinnitus.鼓室内地塞米松治疗急性主观性耳鸣的疗效预测因素。
J Int Adv Otol. 2020 Dec;16(3):338-345. doi: 10.5152/iao.2020.8205.
9
Intratympanic dexamethasone plus melatonin versus melatonin only in the treatment of unilateral acute idiopathic tinnitus.鼓室内注射地塞米松联合褪黑素与单纯使用褪黑素治疗单侧急性特发性耳鸣的比较
Am J Otolaryngol. 2014 Sep-Oct;35(5):617-22. doi: 10.1016/j.amjoto.2014.06.009. Epub 2014 Jul 2.
10
Intratympanic drug therapy with steroids for tinnitus control: a preliminary report.鼓室内注射类固醇药物治疗耳鸣的初步报告。
Int Tinnitus J. 2000;6(1):10-20.

引用本文的文献

1
Easing the Burden of Tinnitus: A Narrative Review for Exploring Effective Pharmacological Strategies.减轻耳鸣负担:探索有效药物治疗策略的叙述性综述
Cureus. 2024 Feb 25;16(2):e54861. doi: 10.7759/cureus.54861. eCollection 2024 Feb.
2
Epidemiology of idiopathic sudden sensorineural hearing loss in the era of big data.大数据时代特发性突发性感音神经性听力损失的流行病学
Eur Arch Otorhinolaryngol. 2023 May;280(5):2181-2190. doi: 10.1007/s00405-022-07693-0. Epub 2022 Oct 14.
3
Effectiveness of Intratympanic Dexamethasone Injection for Tinnitus Treatment: A Systematic Review and Meta-Analysis.
鼓室内注射地塞米松治疗耳鸣的有效性:一项系统评价和荟萃分析
Clin Exp Otorhinolaryngol. 2022 Feb;15(1):91-99. doi: 10.21053/ceo.2021.01459. Epub 2022 Feb 12.
4
Extended High Frequency Audiometry for Revealing Sudden Sensory Neural Hearing Loss in Acute Tinnitus Patients.扩展高频听力测定法用于揭示急性耳鸣患者的突发性感音神经性听力损失
Int Arch Otorhinolaryngol. 2021 Jul;25(3):e413-e415. doi: 10.1055/s-0040-1713921. Epub 2020 Sep 30.
5
Predictive Factors for the Success of Intratympanic Dexamethasone Treatment of Acute Subjective Tinnitus.鼓室内地塞米松治疗急性主观性耳鸣的疗效预测因素。
J Int Adv Otol. 2020 Dec;16(3):338-345. doi: 10.5152/iao.2020.8205.
6
Pharmacotherapy of Tinnitus.耳鸣的药物治疗。
Curr Top Behav Neurosci. 2021;51:193-212. doi: 10.1007/7854_2020_169.
7
Objective Verification of Acute Tinnitus and Validation of Efficacy of Systemic Steroids in Rats.目的:验证急性耳鸣的客观性并验证系统性类固醇在大鼠中的疗效。
J Korean Med Sci. 2020 Apr 6;35(13):e81. doi: 10.3346/jkms.2020.35.e81.
8
Evidence and evidence gaps in tinnitus therapy.耳鸣治疗中的证据与证据空白
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2016 Dec 15;15:Doc04. doi: 10.3205/cto000131. eCollection 2016.